Literature DB >> 28537720

Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances.

Joana Reis1, Alexandra Gaspar1, Nuno Milhazes1, Fernanda Borges1.   

Abstract

The use of privileged structures in drug discovery has proven to be an effective strategy, allowing the generation of innovative hits/leads and successful optimization processes. Chromone is recognized as a privileged structure and a useful template for the design of novel compounds with potential pharmacological interest, particularly in the field of neurodegenerative, inflammatory, and infectious diseases as well as diabetes and cancer. This perspective provides the reader with an update of an earlier article entitled "Chromone: A Valid Scaffold in Medicinal Chemistry" ( Chem. Rev. 2014 , 114 , 4960 - 4992 ) and is mainly focused on chromones of biological interest, including those isolated from natural sources. Moreover, as drug repurposing is becoming an attractive drug discovery approach, recent repurposing studies of chromone-based drugs are also reported.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28537720     DOI: 10.1021/acs.jmedchem.6b01720

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  34 in total

1.  Modeling the structural and reactivity properties of hydrazono methyl-4H-chromen-4-one derivatives-wavefunction-dependent properties, molecular docking, and dynamics simulation studies.

Authors:  Y Sheena Mary; Y Shyma Mary; K S Resmi; S Sarala; Rohitash Yadav; Ismail Celik
Journal:  J Mol Model       Date:  2021-05-26       Impact factor: 1.810

Review 2.  Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics.

Authors:  Hari Madhav; Ehtesham Jameel; Mohammad Rehan; Nasimul Hoda
Journal:  RSC Med Chem       Date:  2022-01-31

3.  Structure-Activity Relationship Analysis of Flavonoids and Its Inhibitory Activity Against BACE1 Enzyme Toward a Better Therapy for Alzheimer's Disease.

Authors:  Nur Intan Saidaah Mohamed Yusof; Zafirah Liyana Abdullah; Norodiyah Othman; Fazlin Mohd Fauzi
Journal:  Front Chem       Date:  2022-06-27       Impact factor: 5.545

4.  Investigation of Direct and Retro Chromone-2-Carboxamides Based Analogs of Pseudomonas aeruginosa Quorum Sensing Signal as New Anti-Biofilm Agents.

Authors:  Jeanne Trognon; Gonzalo Vera; Maya Rima; Jean-Luc Stigliani; Laurent Amielet; Salomé El Hage; Barbora Lajoie; Christine Roques; Fatima El Garah
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-29

5.  Multi-objective de novo drug design with conditional graph generative model.

Authors:  Yibo Li; Liangren Zhang; Zhenming Liu
Journal:  J Cheminform       Date:  2018-07-24       Impact factor: 5.514

6.  Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.

Authors:  Leili Jalili-Baleh; Hamid Nadri; Hamid Forootanfar; Tuba Tüylü Küçükkılınç; Beyza Ayazgök; Mohammad Sharifzadeh; Mahban Rahimifard; Maryam Baeeri; Mohammad Abdollahi; Alireza Foroumadi; Mehdi Khoobi
Journal:  Daru       Date:  2021-01-09       Impact factor: 3.117

7.  Rapid synthetic approaches to libraries of diversified 1,2-dihydrochromeno[2,3-c]pyrrole-3,9-diones and 3-(2-hydroxyphenyl)-4,5-dihydropyrrolo[3,4-c]pyrazol-6(1H)-ones.

Authors:  Roman N Vydzhak; Svitlana Ya Panchishin; Maryna V Kachaeva; Stepan G Pilyo; Viktoriia S Moskvina; Olga V Shablykina; Andriy V Kozytskiy; Volodymyr S Brovarets
Journal:  Mol Divers       Date:  2021-06-04       Impact factor: 3.364

8.  Evaluation of In Vitro Antioxidant and Anticancer Properties of the Aqueous Extract from the Stem Bark of Stryphnodendron adstringens.

Authors:  Débora da Silva Baldivia; Daniel Ferreira Leite; David Tsuyoshi Hiramatsu de Castro; Jaqueline Ferreira Campos; Uilson Pereira Dos Santos; Edgar Julian Paredes-Gamero; Carlos Alexandre Carollo; Denise Brentan Silva; Kely de Picoli Souza; Edson Lucas Dos Santos
Journal:  Int J Mol Sci       Date:  2018-08-17       Impact factor: 5.923

9.  Identification of potent chromone embedded [1,2,3]-triazoles as novel anti-tubercular agents.

Authors:  Viswanadh Nalla; Aslam Shaikh; Sanket Bapat; Renu Vyas; M Karthikeyan; P Yogeeswari; D Sriram; M Muthukrishnan
Journal:  R Soc Open Sci       Date:  2018-04-04       Impact factor: 2.963

10.  Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents.

Authors:  Yuheng Hu; Bing Wang; Jie Yang; Teng Liu; Jie Sun; Xiaojing Wang
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.